Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion type Assertion NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_head.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion description "[The preclinical mutation carrier group 2 scored significantly higher than the nonmutation carrier group for 3 of the SCL-90-R symptom dimensions (anxiety, paranoid ideation, and psychoticism).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_provenance.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion evidence source_evidence_literature NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_provenance.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion SIO_000772 17210818 NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_provenance.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion wasDerivedFrom befree-20140225 NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_provenance.
- NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_assertion wasGeneratedBy ECO_0000203 NP848197.RAQDrCyJfLlIIZVIFU2UGdSODQnJ-Afdb3VRw4u9szOKA130_provenance.